Search clinical trials for: Holocare Studio 2 (HS2)

Total 813 results

Janssen Research & Development, LLC

Completed

Study to Assess the Effects of Esketamine on Safety of On-road Driving in Healthy Participants (DRiVESaFe)

Healthy

Netherlands
Duke University

Completed

Pediatric Pain Optimization After Tonsillectomy

Obstructive Sleep Apnea | Pain, Procedural | Tonsillitis

United States
National Cancer Institute (NCI)

Completed

Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors

Central Nervous System Neoplasm | Solid Neoplasm

United States, Canada
Vanderbilt University Medical Center

Terminated

How Your Patients' Non-REM Sleep Changes On Sedatives in the Intensive Care Units (HYPNOS)

Delirium | Respiratory Failure

United States
University Hospital, Strasbourg, France
EUCLID Clinical Trial Platform; NS-PARK; F-CRIN

Recruiting

Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease. (PIMPARK)

Parkinson Disease

France
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Not yet recruiting

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Plasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Lymphoma | Acute Myeloid Leukemia | Refractory Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Small Lymphocytic Lymphoma | Chronic Myelogenous Leukemia | Refractory Chronic Lymphocytic Leukemia and other conditions

United States
Yaakov Beilin

Terminated

Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline

External Cephalic Version

United States
Emory University
CURE Drug Repurposing Collaboratory (CDRC)

Recruiting

Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

COVID-19

United States
Wake Forest University Health Sciences

Completed

The Effect of Brimonidine

Intraocular Pressure

United States
National Cancer Institute (NCI)

Withdrawn

Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | CNS 2a | CNS 2b | CNS 2c | CNS1
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Bristol-Myers Squibb

Completed

Safety Study of BMS-986202 in Healthy Subjects and to Treat Psoriasis

Psoriasis

Australia
Bristol-Myers Squibb

Completed

Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis

Healthy Subjects

Australia
Sanofi

Completed

Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

Pneumoccocal Immunisation

United States
Australasian Leukaemia and Lymphoma Group
Merck Sharp & Dohme LLC; Novartis Pharmaceuticals

Unknown

Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia (PInNACLe)

Chronic Myeloid Leukaemia

Australia
Yale University
Celgene Corporation

Terminated

A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Advanced Solid Cancers

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma

Lymphoma

United States
Fred Hutchinson Cancer Center

Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

Non-Neoplastic Hematologic and Lymphocytic Disorder

United States
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Fundación Oftalmológica Los Andes
Alcon Research

Not yet recruiting

Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery

Cataract | Dry Eye Syndrome | Dry Eye Disease | Phacoemulsification | Evaporative Dry Eye
Sunnybrook Health Sciences Centre

Active, not recruiting

Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery

Depression | Delirium | Cognitive Impairment | Postoperative Cognitive Dysfunction | Dexmedetomidine

Canada
University of Miami

Completed

Effect of Inhaled Albuterol in Pulmonary Hypertension

Pulmonary Hypertension

United States
Feinstein Institute for Medical Research
Cold Spring Harbor Laboratory

Completed

Dornase Alfa Administered to Patients With COVID-19 (DACOVID) (DACOVID)

COVID-19 | Mechanical Ventilation

United States
Frank Tu
Berlex Foundation

Terminated

Local Anesthetic Treatments for Overactive Bladder

Overactive Bladder

United States
Albert Einstein College of Medicine
National Cancer Institute (NCI)

Terminated

Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Recurrent Adult Acute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia

United States
Centre hospitalier de l'Université de Montréal...
Quebec Researchnetwork on aging

Recruiting

Mirtazapine for Chronic Insomnia in Older Adults (MIRAGE)

Chronic Insomnia

Canada
Calo Psychiatric Center

Completed

Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics

Schizophrenia
Otsuka Pharmaceutical Co., Ltd.

Completed

A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia

Schizophrenia

Japan
Ain Shams University

Completed

Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache

Headache

Egypt
Hospices Civils de Lyon

Terminated

Mirtazapine in Cancer-related Poly-symptomatology (MIR-P)

Neoplasms | Cancer | Neoplasm Metastasis

France
Catherine Naseef Hunter

Completed

Mirtazapine for Treatment of Cancer Associated Anorexia-cachexia (MCACS100)

Advanced Cancer | Cancer Associated Anorexia - Cachexia

Egypt
Actavis Inc.

Completed

A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Mirtazapine 15 mg Tablets Under Non-fasting Conditions

Healthy

United States
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Asthma

United States, Australia, Bulgaria, Canada, Croatia, Germany, Greece, Hungary, Ireland, Israel, New Zealand, Poland, Romania, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
Research Foundation for Mental Hygiene, Inc.
National Institute of Mental Health (NIMH)

Completed

Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial

Posttraumatic Stress Disorder

United States
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

15 mg Mirtazapine Orally Disintegrating Tablets, Fasting

Healthy

United States
University of California, Los Angeles

Completed

Combination Treatment for Augmenting Language in Children With ASD (PIII)

Autism Spectrum Disorder

United States
Janssen Research & Development, LLC

Completed

An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin (COMETA)

Diabetes Mellitus, Type 2

Mexico
LG Chem

Completed

Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

Healthy Male Volunteers

Korea, Republic of
Stanford University

Terminated

Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema (PCTTPL)

Lymphedema | Unspecified Adult Solid Tumor, Protocol Specific

United States
Beijing HuiLongGuan Hospital
Stanley Medical Research Institute

Completed

A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

Schizophrenia

China
National Cancer Institute (NCI)

Active, not recruiting

Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia Without Maturation | Adult Acute Myelomonocytic Leukemia | Alkylating Agent-Related Acute Myeloid... and other conditions

United States
National Cancer Institute (NCI)

Terminated

Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage... and other conditions

United States
National Cancer Institute (NCI)

Terminated

Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific | Cardiac Toxicity

United States
University of Miami

Recruiting

Multimodal Pain Package vs. Regular Formulation for Pain Management in Ambulatory Spinal Surgery

Spinal Disorder

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States

Search clinical trials for: Holocare Studio 2 (HS2)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations